A Systems Level Analysis of Transcriptional Changes in Alzheimer's Disease and Normal Aging

<jats:p>Alzheimer's disease (AD) is a debilitating neurodegenerative disorder affecting millions of elderly individuals worldwide. Advances in the genetics of AD have led to new levels of understanding and treatment opportunities. Here, we used a systems biology approach based on weighted gene coexpression network analysis to determine transcriptional networks in AD. This method permits a higher order depiction of gene expression relationships and identifies modules of coexpressed genes that are functionally related, rather than producing massive gene lists. Using this framework, we characterized the transcriptional network in AD, identifying 12 distinct modules related to synaptic and metabolic processes, immune response, and white matter, nine of which were related to disease progression. We further examined the association of gene expression changes with progression of AD and normal aging, and were able to compare functional modules of genes defined in both conditions. Two biologically relevant modules were conserved between AD and aging, one related to mitochondrial processes such as energy metabolism, and the other related to synaptic plasticity. We also identified several genes that were central, or hub, genes in both aging and AD, including the highly abundant signaling molecule 14.3.3 ζ (<jats:italic>YWHAZ</jats:italic>), whose role in AD and aging is uncharacterized. Finally, we found that presenilin 1 (<jats:italic>PSEN1</jats:italic>) is highly coexpressed with canonical myelin proteins, suggesting a role for<jats:italic>PSEN1</jats:italic>in aspects of glial-neuronal interactions related to neurodegenerative processes.</jats:p>